pharmaphorum November 11, 2022
The lack of diversity in clinical trials has been a topic of debate for decades, but was thrust into the spotlight as the impact of the pandemic on poorer, less educated, and ethnically diverse populations became ever more apparent. So, has the situation started to improve?
Sadly not, says a new report from IQVIA, which looked specifically at the inclusion of Black/African Americans and Hispanics in clinical trials in recent years. Overall, inclusion of both groups falls well short of the 2020 US demographic level of 13.6% for Black/African Americans and 18.9% for Hispanics.
IQVIA’s research has been helped by a “dramatic increase” in diversity data collection in phase 2 and 3 trials in the past six years, which has...